当前位置: X-MOL 学术Sci. Signal. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Timing matters in combination therapy
Science Signaling ( IF 7.3 ) Pub Date : 2020-03-10 , DOI: 10.1126/scisignal.abb5803
Leslie K. Ferrarelli 1
Affiliation  

Subsequent, not concurrent, treatment with CDK4/6 inhibitors improves the efficacy of chemotherapy.



中文翻译:

联合疗法的时机很重要

随后但非同时进行的CDK4 / 6抑制剂治疗可提高化疗的疗效。

更新日期:2020-03-10
down
wechat
bug